Taysha Gene Therapies, Inc. (TSHA) Capital expenditures 2020–2025
Taysha Gene Therapies, Inc. (TSHA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$738,000FY2025 · since FY2020: $82,000 → $738,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $738,000 | +97.3% |
| FY2024 | $374,000 | -90.3% |
| FY2023 | $3.9M | -81.2% |
| FY2022 | $20.6M | +34.7% |
| FY2021 | $15.3M | +18563.4% |
| FY2020 | $82,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice